MRFAP1L1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.79439999969944E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.915920E-03 |
Normal-vs-Stage2 |
2.403300E-04 |
Normal-vs-Stage3 |
5.18509679636736E-11 |
Normal-vs-Stage4 |
1.92870164283931E-11 |
Stage1-vs-Stage2 |
1.171220E-01 |
Stage1-vs-Stage3 |
2.27679999997843E-06 |
Stage1-vs-Stage4 |
7.05830000002905E-07 |
Stage2-vs-Stage3 |
1.602850E-01 |
Stage2-vs-Stage4 |
8.686200E-02 |
Stage3-vs-Stage4 |
6.289200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.69749999612279E-08 |
Normal-vs-AfricanAmerican |
1.829350E-01 |
Normal-vs-Asian |
6.491700E-02 |
Caucasian-vs-AfricanAmerican |
1.277730E-02 |
Caucasian-vs-Asian |
8.411800E-01 |
AfricanAmerican-vs-Asian |
4.233400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.25029994638248E-09 |
Normal-vs-Female |
1.260480E-03 |
Male-vs-Female |
8.992800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.467800E-02 |
Normal-vs-Age(41-60Yrs) |
2.22849999998997E-05 |
Normal-vs-Age(61-80Yrs) |
3.84499999617205E-08 |
Normal-vs-Age(81-100Yrs) |
9.88720000000276E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.991200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.531200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.308800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.107200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.529830E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.133000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
1.589030E-01 |
Normal-vs-Grade 2 |
4.675300E-03 |
Normal-vs-Grade 3 |
2.69529953911274E-11 |
Normal-vs-Grade 4 |
5.77993208850103E-12 |
Grade 1-vs-Grade 2 |
8.097200E-03 |
Grade 1-vs-Grade 3 |
1.16380000003691E-06 |
Grade 1-vs-Grade 4 |
7.58910000397961E-08 |
Grade 2-vs-Grade 3 |
6.54759999996202E-07 |
Grade 2-vs-Grade 4 |
3.59709999564473E-08 |
Grade 3-vs-Grade 4 |
7.518100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.617580E-02 |
Normal-vs-ccB subtype |
9.15223452579994E-12 |
ccA subtype-vs-ccB subtype |
2.05589989477062E-11 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.68190000044066E-07 |
Normal-vs-N1 |
1.1130999999498E-06 |
N0-vs-N1 |
3.448300E-02 |
|
|